Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew Su
Institution:
Icahn School of Medicine at Mount Sinai
Observed institutions:
Tisch Cancer Institute,
Icahn School of Medicine at Mount Sinai
ORCID:
0009-0009-9689-5446
Observed ORCID:
0009-0009-9689-5446
OpenAlex ID:
A5108980633
Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis
2024
·
Matthew D. Park
, Jessica Le Berichel
, et al.
·
Science
·
141
PDF
902 Hematopoietic aging promotes cancer by fueling IL-1α-driven emergency myelopoiesis
2024
·
Matthew D Park
, Jessica Le Berichel
, et al.
·
Regular and Young Investigator Award Abstracts
·
4
Abstract CT106: A phase 1b/2 trial of dupilumab given in conjunction with PD-1 or PD-L1 blockade and anakinra in the treatment of relapsed/refractory metastatic NSCLC
2025
·
Jacob A. Lowy
, Matthew D. Park
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
145
H-index:
2
I10-index:
1
Year
Topic
Type